Kimberly-Clark to Acquire Kenvue in $48.7 Billion Deal
Kimberly-Clark has agreed to acquire Kenvue, the maker of Tylenol, Band-Aid, and Benadryl, in a $48.7 billion cash-and-stock transaction.
The deal unites some of the world's best-known consumer health and personal care brands, positioning the combined company as a global powerhouse in the consumer staples sector.
- Shares of Kenvue jumped 15% in early trading following the announcement.
- Kimberly-Clark stock fell 12% as investors weighed the scale of the purchase.
The merger, approved by both companies' boards, is expected to close in the second half of 2026, pending regulatory and shareholder approval.
Kenvue shareholders will receive $3.50 in cash and 0.14625 Kimberly-Clark shares for each Kenvue share held, amounting to approximately $21.01 per share based on Kimberly-Clark's stock price.
Author's summary: Kimberly-Clark acquires Kenvue for $48.7 billion.
More News
- Tulsa businesses helping SNAP recipients: Where to donate food and volunteer
- Report: Boxing legend tabbed to potentially replace Gervonta Davis showdown vs. Jake Paul | BJPenn.com
- The Start in Riyadh Season.. Mohammad Fadel Shaker Returns to the Stage After Progress in the Investigations with His Father
- COLUMN: The duality of the house of Bannister - Fredericksburg Free Press
- Dennis Harold Benefield
- Will Prop 50 prompt a Pelosi exit? California waits on pins and needles
- Britney Spears deleted her Instagram account amidst concern for her health
- Will Prop 50 prompt a Pelosi exit? California waits on pins and needles
- Jake Paul searching for other fighters to replace Gervonta 'Tank' Davis after civil suit - Face2Face Africa